NCT06268002

Effect of Vernonia Cinerea Lozenges as a Smoking Cessation Aid in Patients With Non-communicable Diseases

Name: Clinical Trial NCT06268002
Creator: Chulalongkorn University
Keywords: Smoking Cessation, Vernonia cinerea, dietary supplement, clinical trial, Thailand

Chulalongkorn University·ClinicalTrials.gov·dietary supplementCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Smoking Cessation
Drug/Device/Intervention: Vernonia cinerea
Study type: Interventional
Intervention type: dietary supplement

Sponsor & location

Primary sponsor: Chulalongkorn University
Location: Bangkok, Thailand

Timeline & enrollment

Phase: N/A
Start date: Sep 01, 2017
End date: Dec 31, 2021
Enrollment: 93 participants

Primary outcome

continuous abstinence rate

Summary

Vernonia cinerea is an herbal which has been recorded in many Thai herbal formulation and Thai traditional medicine has used this herbal for treating various diseases included hypertension, asthma, fever, hepatitis, kidney stone and smoking cessation. Now aday there are more interest for using Vernonia cinerea as a medication to aid smoker to quit smoking because it is cheaper than other current therapeutic medications. The objective of this study is to evaluate efficacy and safety of Vernonia cinerea lozenge for smoking cessation when compared to placebo.

ICD-10 classifications

Mental and behavioural disorders due to use of tobacco withdrawal stateTobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06268002
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06268002 through Pure Global AI's free database. This phase not specified trial is sponsored by Chulalongkorn University and is currently Completed. The study focuses on Smoking Cessation. Target enrollment is 93 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.